IRIS
DI MARCO, Roberto Maria Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.565
AS - Asia 1.617
EU - Europa 1.596
SA - Sud America 338
AF - Africa 148
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.444
SG - Singapore 890
IT - Italia 527
CN - Cina 421
IE - Irlanda 371
BR - Brasile 315
UA - Ucraina 301
HK - Hong Kong 212
CA - Canada 111
CI - Costa d'Avorio 94
DE - Germania 93
RU - Federazione Russa 86
SE - Svezia 79
SN - Senegal 36
GB - Regno Unito 25
AT - Austria 20
IN - India 18
FR - Francia 17
CH - Svizzera 13
NL - Olanda 13
FI - Finlandia 11
TR - Turchia 11
IR - Iran 10
VN - Vietnam 10
AR - Argentina 9
BG - Bulgaria 9
UZ - Uzbekistan 9
GR - Grecia 8
PL - Polonia 8
AU - Australia 7
IQ - Iraq 6
PK - Pakistan 6
BE - Belgio 5
MA - Marocco 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EU - Europa 3
ID - Indonesia 3
MK - Macedonia 3
MX - Messico 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BO - Bolivia 2
CO - Colombia 2
DZ - Algeria 2
GE - Georgia 2
JO - Giordania 2
KR - Corea 2
LB - Libano 2
LT - Lituania 2
MY - Malesia 2
NG - Nigeria 2
PH - Filippine 2
TN - Tunisia 2
VE - Venezuela 2
AO - Angola 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.276
Salva come PNG Salva come JPEG
Città #
Santa Clara 907
Singapore 455
Jacksonville 391
Dublin 371
Chandler 277
Houston 211
Civitanova Marche 167
Boardman 162
Catania 146
Chicago 132
Nanjing 104
Cambridge 100
Andover 99
Lawrence 99
Abidjan 94
Toronto 89
Hefei 76
Ashburn 51
San Mateo 48
Des Moines 45
Wilmington 45
Grafing 38
Dakar 36
Hebei 32
Nanchang 30
São Paulo 23
Jiaxing 22
Ottawa 21
Saint Petersburg 18
Shenyang 18
Campobasso 17
Changsha 17
Tianjin 17
The Dalles 14
Naples 13
Rio de Janeiro 13
Bremen 12
Rome 12
Hangzhou 11
Moscow 11
Dong Ket 10
Los Angeles 9
Maletto 9
Munich 9
Palermo 9
Salerno 9
Vienna 8
Curitiba 7
Leawood 7
Milan 7
Mountain View 7
Norwalk 7
Nuremberg 7
Washington 7
Belo Horizonte 6
Lappeenranta 6
Seattle 6
Ardabil 5
Augusta 5
Brasília 5
Brussels 5
Frankfurt Am Main 5
Juiz de Fora 5
Kunming 5
Padova 5
Porto Alegre 5
San Francisco 5
Baghdad 4
Beijing 4
Brooklyn 4
Chiaramonte Gulfi 4
Council Bluffs 4
Hortolândia 4
London 4
Molise 4
Ningbo 4
Phoenix 4
Pozzallo 4
Viçosa 4
Ann Arbor 3
Baku 3
Betim 3
Caruaru 3
Casablanca 3
Città Sant'Angelo 3
Dearborn 3
Den Haag 3
Edinburgh 3
Falls Church 3
Florence 3
Fortaleza 3
Foz do Iguaçu 3
Goiânia 3
Guangzhou 3
Guarulhos 3
Hanover 3
Helsinki 3
Hong Kong 3
Istanbul 3
Kochi 3
Totale 4.735
Salva come PNG Salva come JPEG
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 301
N-acetylcysteine causes analgesia by activating group II metabotropic glutamate receptors 269
Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. 258
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 103
Expression of the oas gene family is highly modulated in subjects affected by juvenile dermatomyositis, resembling an immune response to a dsRNA virus infection 78
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 78
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 76
Validità dell’autotrapianto di milza nella difesa dalle infezioni batteriche. Ricerche sperimentali 74
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 72
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease 68
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 68
Microbiological and clinical periodontal effects of fixed orthodontic appliances in pediatric patients 68
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 67
Immunomodulatory properties of cefaclor: In vivo effect on cytokines release and lymphoprolipherative response on rat 66
Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoiimune diabetes in male NOD mice 66
Sodium fucidate (fusidin) ameliorates the course of monophasic experimantal allergic encephalomyelitis in the Lewis rat 65
Increased rate of survial in streptococcus pneumoniae -infected rats treated with the new immunomodulator pitotimod 65
Preliminary in vitro studies on Corynebacterium urealyticum pathogenetic mechanisms, a possible candidate for chronic idiopathic prostatitis? 65
Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: FC construct 64
DATI PRELIMINARI SULLE MODIFICAZIONI DI ALCUNI PARAMETRI DEL SISTEMA IMMUNITARIO UMANO INDOTTE DAL TRATTAMENTO CON CEFACLOR 64
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 64
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 63
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 63
In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse 62
FK-506 prevents diabetes in diabetes-prone BB/Wor rats 62
Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery 62
Probiotics:overview of microbiological and immunological characteristics 60
Expression of DNA methylation genes in secondary progressive multiple sclerosis 60
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis 60
Dati preliminari sulle modificazioni di alcuni parametri del sistema immunitario umano indotte dal trattamento con cefaclor 60
The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse 59
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 59
Murine Concanavalin A-induced hepatitis is prevented by interleukin 1 exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism 58
Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14 58
Calcium butyrate: Anti-inflammatory effect on experimental colitis in rats and antitumor properties 58
Therapeutic effects of single administration of Cyclophosphamide in rat experimental autoimmune neuritis, a pre-clinical model of autoimmune peripheral neuropathies 57
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 57
Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution 57
Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock 57
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 57
Sodium fusidate in Guillain-Barre syndrome: a case report 56
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 56
Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-y 55
Glycopeptide- and carbohydrate-based synthetic vaccines for cancer immunotherapy 55
THE EFFECT OF CEFEPIME ON SOME IMMUNE PARAMETERS IN-VITRO - LACK OF INTERFERENCE WITH MITOGEN-INDUCED LYMPHOPROLIFERATION, IMMUNOGLOBULIN-SYNTHESIS, IFN-GAMMA AND IL-2 SECRETION AND IL-2 RECEPTOR EXPRESSION 55
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 54
Bactericidal activity and postantibiotic effect of cefdnir (ci 983, fk 482) against selected athogens 54
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 54
Protection from concanavalin A (Con A) induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate 53
The Effects of Deoxyspergualin on the Development of Diabetes in Diabetes‐Prone BB Rats 53
Increased serum levels of interleukin-18 in patients with multiple sclerosis 53
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 53
Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures 53
Correlation of the persistence or eradication of Porphyromonas gingivalis with pocket depht reduction in the treatment of periodontal disease 53
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 52
Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody 52
Protection from Experimental Autoimmune Thyroiditis in CBA Mice with the Novel Immunosuppressant Deoxyspergualin 52
Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin 52
Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies 51
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism 51
Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy? 51
Short-term treatment of relapsing remitting Multiple sclerosis patients with interferon (INF)-beta 1B transiently increases the blood levels of Interleukine (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta IL-2, IL-4 and Tumor necrosis factors-alfa 49
Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency 47
Blood levels of transforming growth factor-beta 1 (TGF-beta 1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta 1b) 47
The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse 47
Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor 45
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome 45
A Potential "Vitaminic Strategy" against Caries and Halitosis 45
Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat 44
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 43
Epidemiology of antibiotic resistance in human isolates of Enterobacteriaceae in Sicily 43
Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis 43
Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat 42
INCREASE OF SOLUBLE CD30 (SCD30) AND EOSINOPHIL COUNT IN MYELOMA PATIENTS TREATED WITH A REGIMEN INCLUDING THALIDOMIDE 42
Effetti della somministrazione di un enterovaccino nella profilassi delle cistiti e vaginiti ricorrenti 42
Synergistic effect of deoxyspergualin (DSP) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats 41
Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice 41
The Effects of Thymopentin on the Development of SLE‐Like Syndrome in the MRL/lpr‐lpr Mouse 41
In Vitro and In Vivo Biological Activity of Berberine Chloride against Uropathogenic E. coli Strains Using Galleria mellonella as a Host Model 41
Human breast milk isolated lactic acid bacteria: antimicrobial and immunomodulatory activity on the Galleria mellonella burn wound model 40
Correlation of the persistance or eradication of Porphyromonas gingivalis with pochet depth reduction in the treatment of periodontal Disease 40
Synergistic effect of deoxyspergualin (DPS) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats 40
INCREASED RATE OF SURVIVAL IN STREPTOCOCCUS PNEUMONIAE-INFECTED RATS TREATED WITH THE NEW IMMUNOMODULATOR PIDOTIMOD 39
Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice 39
Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin. 39
Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB rats 38
Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice 38
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 37
Neopterin: a potential marker in chronic peripheral arterial disease 37
Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment 36
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review 36
The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta 1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells 35
Pharmacological profile of 9,11-dehydrocortexolone 17alpha-butyrate (CB-03-04), a new androgen antagonist with antigonadotropic activity 35
Upregulated expression of macrophage migration inhibitory factor, its analogue d-dopachrome tautomerase, and the cd44 receptor in peripheral cd4 t cells from clinically isolated syndrome patients with rapid conversion to clinical defined multiple sclerosis 35
Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet 34
Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis 33
COMPOSITION FOR THE PREVENTION AND TREATMENT OF ACUTE AND RECURRENT URINARY TRACT INFECTIONS 32
Potential mucosal irritation discrimination of surface disinfectants employed against sars-cov-2 by limacus flavus slug mucosal irritation assay 31
Symbiotic Wolbachia in mosquitoes and its role in reducing the transmission of mosquito-borne diseases: updates and prospects 29
Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody 29
Totale 5.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202086 0 0 0 0 0 0 0 0 0 0 60 26
2020/2021637 22 42 80 4 149 16 78 2 77 2 127 38
2021/2022700 87 101 3 16 109 9 104 14 68 0 22 167
2022/20231.257 101 29 14 76 90 195 5 381 285 14 48 19
2023/2024457 21 65 20 42 19 101 5 35 2 17 83 47
2024/20253.357 8 292 119 483 923 305 200 148 330 375 174 0
Totale 7.628